Marc Wilson - Dec 31, 2021 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
CFO
Signature
/s/ Marc Wilson
Stock symbol
CRNX
Transactions as of
Dec 31, 2021
Transactions value $
$21,236
Form type
5
Date filed
2/4/2022, 03:30 PM
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $12K +1.09K +1.81% $11.02 61.3K May 20, 2021 Direct F1
transaction CRNX Common Stock Other $9.22K +837 +1.37% $11.02 62.1K Nov 19, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).